Skip to main
VTR

Ventas (VTR) Stock Forecast & Price Target

Ventas (VTR) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 14%
Buy 64%
Hold 21%
Sell 0%
Strong Sell 0%

Bulls say

Ventas is supported by a diversified healthcare real estate platform of nearly 1,400 properties across senior housing, medical office, hospital, life science, and skilled nursing/post-acute care, plus a small loan portfolio that contributes about 1% of NOI. Its positive outlook is anchored in strong SHOP operating momentum, with same-store NOI growth of 15.4% in 1Q26 and 15.9% YTD, alongside elevated occupancy and management guidance of 15-17% full-year growth in 2026. The company also has a robust investment runway, targeting about $3.0 billion of annual acquisitions in 2026 with deals still underwriting to low- to mid-teens IRRs, while net debt to EBITDA improved to 5.0x in 1Q26 and the stock benefits from a leading sustainability profile.

Bears say

Ventas is exposed to a potentially less favorable mix of healthcare real estate risks, as its nearly 1,400-property portfolio spans senior housing, medical office, hospitals, life science, and skilled nursing/post-acute care, with about 100 assets in Canada and the United Kingdom and mortgages/loans adding only about 1% of NOI. The bearish view is driven by the expectation that today’s elevated seniors housing growth normalizes back toward historical ranges, which would compress valuation multiples and temper the company’s 7-year growth outlook despite still-respectable fundamentals. Additional pressure could come from tighter capital availability, rising competition from private buyers, renewed supply in SHOP, and regulatory or NIH budget changes that could affect its 8% Wexford/R&I exposure.

Ventas (VTR) has been analyzed by 14 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 64% recommend Buy, 21% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ventas and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ventas (VTR) Forecast

Analysts have given Ventas (VTR) a Buy based on their latest research and market trends.

According to 14 analysts, Ventas (VTR) has a Buy consensus rating as of Oct 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $100.07, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $100.07, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ventas (VTR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.